Modelling the Anti-Migraine Effects of BIBN 4096 BS: A New Calcitonin Gene-Related Peptide Receptor Antagonist

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.45, Iss.7, 2006-01, pp. : 715-728

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Calcitonin gene-related peptide receptor antagonists for migraine

By Fischer Michael JM

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 7, 2010-07 ,pp. : 815-823

Informa Healthcare

Access to resources Recommend Favorite

Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [ 3 H]BIBN4096BS

By Schindler M. Doods H.N.

European Journal of Pharmacology, Vol. 442, Iss. 3, 2002-05 ,pp. : 187-193

Elsevier

Access to resources Recommend Favorite

New drugs for the prevention and treatment of migraine: topiramate and BIBN 4096 BS

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 8, 2004-08 ,pp. : 1837-1840

Informa Healthcare

Access to resources Recommend Favorite

Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists in the Treatment of Migraine

By Durham Paul L. Vause Carrie V.

CNS Drugs, Vol. 24, Iss. 7, 2010-07 ,pp. : 539-548

Adis International

Access to resources Recommend Favorite

Discovery techniques for calcitonin gene-related peptide receptor antagonists for potential antimigraine therapies

By Labruijere Sieneke Ibrahimi Khatera Chan Kayi Y MaassenVanDenBrink Antoinette

Expert Opinion on Drug Discovery, Vol. 8, Iss. 11, 2013-11 ,pp. : 1309-1323

Informa Healthcare

Access to resources Recommend Favorite